Literature DB >> 18222614

Parameters of delay discounting assessment: number of trials, effort, and sequential effects.

Elias Robles1, Perla A Vargas.   

Abstract

Procedural variants in estimating delay discounting (DD) have been shown to yield significant within-subject differences in estimated degree of delay discounting as well as variations in the patterns of choice. The purpose of this study was to evaluate the effect of subject control over the number of trials in a delay discounting task, on degree of delay discounting. Participants were assessed with two computerized DD assessments: the full-length method presented participants with a fixed set of 240 trials, and the abbreviated task, where once participants had shown indifference between the immediate and delayed rewards, the remaining trials for that delay value were omitted. While the full-length and abbreviated methods did not differentially affect patterns of choice or estimated delay discounting, the order of presentation (ascending or descending) of immediate rewards produced differences in each measure: rate of delay discounting was significantly lower when estimated with the descending sequence; a larger proportion of area under the discounting curve was concentrated around the indifference point trial with the descending sequence; and a lower correlation was observed between estimates obtained across methods with the descending sequence.

Entities:  

Mesh:

Year:  2007        PMID: 18222614     DOI: 10.1016/j.beproc.2007.10.012

Source DB:  PubMed          Journal:  Behav Processes        ISSN: 0376-6357            Impact factor:   1.777


  19 in total

Review 1.  Intergenerational transmission of self-regulation: A multidisciplinary review and integrative conceptual framework.

Authors:  David J Bridgett; Nicole M Burt; Erin S Edwards; Kirby Deater-Deckard
Journal:  Psychol Bull       Date:  2015-05       Impact factor: 17.737

2.  A long-term study of the impulsive choices of Lewis and Fischer 344 rats.

Authors:  Carlos F Aparicio; Mirari Elcoro; Benigno Alonso-Alvarez
Journal:  Learn Behav       Date:  2015-09       Impact factor: 1.986

3.  Drug Discrimination and the Analysis of Private Events.

Authors:  Brian D Kangas; David R Maguire
Journal:  Behav Anal (Wash D C)       Date:  2016-03-14

4.  Estimating the subjective value of future rewards: comparison of adjusting-amount and adjusting-delay procedures.

Authors:  Daniel D Holt; Leonard Green; Joel Myerson
Journal:  Behav Processes       Date:  2012-03-14       Impact factor: 1.777

5.  Effects of NMDA receptor antagonists on probability discounting depend on the order of probability presentation.

Authors:  Justin R Yates; Kerry A Breitenstein; Benjamin T Gunkel; Mallory N Hughes; Anthony B Johnson; Katherine K Rogers; Sara M Shape
Journal:  Pharmacol Biochem Behav       Date:  2016-09-15       Impact factor: 3.533

6.  Delay discounting, impulsiveness, and addiction severity in opioid-dependent patients.

Authors:  Elias Robles; B Emma Huang; Pippa M Simpson; Donald E McMillan
Journal:  J Subst Abuse Treat       Date:  2011-07-07

7.  Delay discounting behavior and white matter microstructure abnormalities in youth with a family history of alcoholism.

Authors:  Megan M Herting; Daniel Schwartz; Suzanne H Mitchell; Bonnie J Nagel
Journal:  Alcohol Clin Exp Res       Date:  2010-06-25       Impact factor: 3.455

8.  INTERTEMPORAL DECISION-MAKING FOR A GROUP.

Authors:  Richard Yi; Leila F King; Anne E Carter; Reid D Landes; Warren K Bickel
Journal:  Psychol Rec       Date:  2010

9.  Discounting of monetary rewards that are both delayed and probabilistic: delay and probability combine multiplicatively, not additively.

Authors:  Ariana Vanderveldt; Leonard Green; Joel Myerson
Journal:  J Exp Psychol Learn Mem Cogn       Date:  2014-06-16       Impact factor: 3.051

10.  Heroin delay discounting: Modulation by pharmacological state, drug-use impulsivity, and intelligence.

Authors:  Jonathan J K Stoltman; Eric A Woodcock; Jamey J Lister; Leslie H Lundahl; Mark K Greenwald
Journal:  Exp Clin Psychopharmacol       Date:  2015-12       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.